Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SAU:4013's 9-Day RSI is ranked worse than 97.7% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 48.43
vs SAU:4013: 82.63
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Dr Sulaiman Al Habib Medical Services Group 9-Day RSI Related Terms
SAU:4013 vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group 9-Day RSI vs Healthcare Providers & Services Industry
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a 9-Day RSI of 82.63 as of Jul. 29, 2026. According to the industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #681 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 97.7%.
Is Dr Sulaiman Al Habib Medical Services Group's 9-Day RSI too high?
Dr Sulaiman Al Habib Medical Services Group's current 9-Day RSI is 82.63. The Healthcare Providers & Services industry median 9-Day RSI is 48.43. Dr Sulaiman Al Habib Medical Services Group's value of 82.63 is 70.6% above this industry median. Based on the distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #681 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #681 out of 697 companies for 9-Day RSI. This places Dr Sulaiman Al Habib Medical Services Group in the lower half of its industry. The industry median 9-Day RSI is 48.43. Dr Sulaiman Al Habib Medical Services Group's value of 82.63 is 70.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 48.43, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current 9-Day RSI of 82.63 is 70.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 48.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current 9-Day RSI is 82.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼398.19, compared to a current price of ﷼237.10 — trading 40.5% below its estimated fair value. The current 9-Day RSI is 82.63 and 70.6% above the Healthcare Providers & Services industry median of 48.43. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current 9-Day RSI is 82.63 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼237.10 is trading 40.5% below its estimated GF Value™ of ﷼398.19.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
9-Day RSI: 82.63
GF Value™: ﷼398.19 vs. price of ﷼237.10 (40.5% below fair value)
Industry Position: 70.6% above the Healthcare Providers & Services median (#681 of 697)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group Business Description
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
93GF Score
Get the complete analysis for SAU:4013
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
